Patient Voice, • 9/19/25 Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Previous How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Next Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials You Might Also Like Aligning Trials with Patient-Lived Experiences AI-Driven Patient Identification and Recruitment Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Solutions for Trial Design Challenges in Rare Disease Trials
Patient Voice, • 9/19/25 Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Previous How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Next Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials You Might Also Like Aligning Trials with Patient-Lived Experiences AI-Driven Patient Identification and Recruitment Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Solutions for Trial Design Challenges in Rare Disease Trials
